Frost & Sullivan Applauds the Lodox Statscan Critical Imaging System for Outperforming All Competing Products

LONDON, August 31, 2010 - Following a recent analysis of the medical imaging devices market, Frost
& Sullivan presented Lodox Systems (Pty) Ltd (Lodox) with the "2010 South
African Medical Imaging Product Quality Leadership Award". Statscan, Lodox's
digital x-ray product, stunned the market with its ability to produce clear,
diagnostic, whole-body x-ray pictures in just 13 seconds.

    (Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
    (Logo: www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Presently, the majority of imaging products on the market fail to
generate critical information at a fast enough speed. To enhance the chances
of survival for trauma patients, emergency centres require equipment
supplying top-quality information in the least amount of time possible.
Lodox's Statscan is a flexible format digital radiography (DR) system,
specifically designed to meet the needs of emergency medical centres, as well
as the radiography needs of both trauma and emergency patients. The system
uniquely provides a complete, head-to-toe summary of patient injuries, at an
increasingly faster rate than before, while avoiding any interference with
patient stability.

"The Statscan ensures easy access to the patient at an extremely low
radiation dose so that the ER staff can continue to provide critical life
support," says Frost & Sullivan Research Analyst Ishe Zingoni. "The entire
body is scanned, minimizing unnecessary manoeuvering and quickly picking up
multiple injuries that do not always show up in conventionally-sized x-rays."

For triage, and in disaster situations, the radiography-friendly Statscan
is able to handle multiple patients more efficiently than competing
modalities. Positive outcomes are enhanced, not only for patients, but also
for ER staff, who are subject to extreme stress when having to make
less-informed decisions within the "golden hour".

"The quality of Statscan sets a benchmark that surpasses present industry
standards," notes Zingoni. "It outperforms competitor products in three
primary ways: by the quality of its high-resolution pictures, the capacity of
the size of an image (whole body), and the extraordinary speed."

The Statscan system is exceedingly reliable, consistently performing to
the highest expectations. This dependable workability is reaffirmed by the
trend of infrequent technical malfunction in Lodox equipment. In the rare
event of a technical problem with equipment, Lodox's presence extends to
major metropolitan areas, enabling a speedy response. As the company is
close-knit and small, with a mere 25 people employed, response time is
significantly enhanced.

According to its design, Statscan does not require film processing. This
is greatly advantageous, as it reduces heavy operating costs. Also, the
technology used in Statscan employs the safest x-ray method available for
healthcare personnel. The precisely aimed, low-dose radiation beam produces
no scattered radiation, making the system secure and easy to operate. Thus,
less-skilled operators can more safely produce high quality images with
Statscan, due to the smaller radiation dose, than with alternative competitor
products.

Lodox's latest Statscan installations took place in the Ngwelezana
Hospital, Charlotte Maxeke Academic Hospital and Chris Hani Baragwanath
Hospital in December 2009. The company has also installed its equipment in
other provinces, maintaining a varied clientele of public and private
hospitals. In addition to emergency trauma centres, the system has multiple
applications in areas such as forensic pathology, high throughput general
radiology and paediatric radiology. As a result, the Statscan system scored
higher than competing products in terms of reliability, design and usability
as well.

Most importantly, Statscan provides all these benefits for clients and
patients at a reasonable price. The equipment sells for between R3 million
and R3.5 million (depending on additional features required), placing it in
the middle range. It is particularly well-priced as compared to other
standard DR and Flat Panel systems; thus, Statscan is highly competitive,
offering better value for money than its counterparts on the market.

For these achievements and high value offerings, Lodox is the deserving
recipient of the 2010 South African Medical Imaging Product Quality
Leadership Award in the medical imaging market. Each year, Frost & Sullivan
presents this award to a company whose product has demonstrated outstanding
quality in terms of performance, reliability, design, usability, and
perceived value.

Frost & Sullivan Best Practices Awards recognize companies in a variety
of regional and global markets for demonstrating outstanding achievement and
superior performance in areas such as leadership, technological innovation,
customer service, and strategic product development. Industry analysts
compare market participants and measure performance through in-depth
interviews, analysis, and extensive secondary research in order to identify
best practices in the industry.

About Lodox

Lodox is responsible for worldwide sales, distribution and customer
service support of the new innovation known as Statscan. The company is based
in Johannesburg, and it is a venture capital backed private corporation
registered in South Africa. Lodox's present principal equity partner is the
Industrial Development Corporation of South Africa (IDC).

    Lodox Contact Information
    Pieter de Beer - Chief Executive Officer
    Phone: +27-11-444-9118 (office) or +27-71-671-8750 (mobile)
    E-mail: pieter.debeer@lodox.com

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to
accelerate growth and achieve best-in-class positions in growth, innovation
and leadership. The company's Growth Partnership Service provides the CEO and
the CEO's Growth Team with disciplined research and best-practice models to
drive the generation, evaluation, and implementation of powerful growth
strategies. Frost & Sullivan leverages over 45 years of experience in
partnering with Global 1000 companies, emerging businesses and the investment
community from 40 offices on six continents. To join our Growth Partnership,
please visit www.awards.frost.com.

    Frost & Sullivan Contact Information
    Chiara Carella
    Corporate Communications - Europe
    P: +44-0-20-7343-8314
    E: chiara.carella@frost.com

Chiara Carella, Corporate Communications - Europe of Frost & Sullivan, +44-(0)-20-7343-8314, chiara.carella at frost.com; or Pieter de Beer, Chief Executive Officer of Lodox, +27-11-444-9118, mobile, +27-71-671-8750, pieter.debeer at lodox.com